Trial Profile
A double-blind, randomized, parallel-group, placebo-controlled, multiple-dose study to assess the effect of 125 mg/day orally administered azimilide dihydrochloride on renal function and hemodynamics in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Azimilide (Primary)
- Indications Ventricular arrhythmias
- Focus Pharmacodynamics
- Sponsors Procter & Gamble
- 10 Nov 2006 New trial record.